drugset / Trial / NCT03315611

Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis

NCT03315611 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to assess the effect of 'Eucerin AtopiControl LOTION' and 'Eucerin AtopiControl facial cream' on dermal symptoms in patients with Atopic Dermatitis (AD) after two 4 h challenges with grass pollen on two consecutive days. In addition, this clinical study with exposure of Dactyls glomerate-sensitized Patients with AD shall be used to compare the skin response with AD Patients not-sensitized to Dactylis glomerata to understand the specificity of the grass pollen exposure.

Timeline

Start
2017-10-02
Primary completion
2018-04-25
Completion
2018-04-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eucerin AtopiControl Lotion Unknown 1.2 g Topical